Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ahmad AL-Sabbagh
Comparing the Cost-Effectiveness of Disease-Modifying Drugs for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis
Journal of Managed Care Pharmacy
Related publications
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Archives of Neurology
Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Pnd60 - Cost-Effectiveness of Teriflunomide for the Treatment of Relapsing-Remitting Multiple Sclerosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd73 - The Impact of Modelling Subsequent Treatment on Estimates of Cost-Effectiveness: An Analysis of Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd120 - Treatment Decisions About First-Line Disease-Modifying Treatments (Dmts) in Relapsing Remitting Multiple Sclerosis: A Systematic Review of Patient Needs and Preferences
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparing the Quality of Life Among Patients With Relapsing Remitting Multiple Sclerosis in Iraq Using Different Disease Modifying Therapies
Iraqi Journal of Pharmaceutical Sciences
Toxicology
Analytical Chemistry
Pharmaceutics
Pharmacology
Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Cladribine Tablets, Alemtuzumab and Natalizumab in the Treatment of Relapsing-Remitting Multiple Sclerosis With High Disease Activity in England
Journal of Medical Economics
Health Policy
Pnd65 - Cost-Effectiveness Analysis of Drugs Used for the Treatment of Highly Active Relapsing Multiple Sclerosis in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
